Antabuse

Quick links to important sections

Antabuse

Treatment option: Alcoholism

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Antabuse

Property Description
Active ingredient Disulfiram (INN)
Form Oral tablet
Pharmacological class Aldehyde Dehydrogenase Inhibitor, Alcohol Antagonist Drug
Common use Support for Alcohol Use Disorder (AUD) abstinence
Origin Synthetic (Carbamate derivative)

What is Disulfiram (Antabuse) and Its Pharmacological Class?

Disulfiram is the active ingredient in the medication most frequently associated with the trade name Antabuse, and it is scientifically classified as an alcohol antagonist drug and an Aldehyde Dehydrogenase Inhibitor. This synthetic compound, a carbamate derivative, is obtained only by prescription. It serves as a deterrent agent for Alcohol Use Disorder (AUD). Disulfiram helps reinforce an individual’s commitment to abstinence by creating an unavoidable physical reaction to alcohol. Disulfiram functions primarily as an alcohol-aversive agent, a key differentiator from other Medication-Assisted Treatment (MAT) options that focus on managing cravings, instead supporting continuous sobriety within a structured recovery program.


Composition and Form: What Kind of Medication Is It?

Disulfiram is supplied as a single-ingredient product in a solid oral tablet form, intended for the oral route of administration. The drug is designed to deliver the sole active compound, Disulfiram, efficiently into the system, utilizing inert excipients as the necessary base/vehicle for the solid preparation. This oral form ensures consistent absorption, allowing the active agent to establish a sustained level of Aldehyde Dehydrogenase (ALDH) inhibition in the body. The medication is intended to assist in preventing relapses in motivated individuals undergoing treatment. The drug’s metabolic action provides a safeguard against alcohol consumption. The resulting inhibition leads to the critical buildup of the toxic substance acetaldehyde when alcohol is consumed, which immediately produces the highly unpleasant physical symptoms of the Disulfiram-alcohol reaction, reinforcing the deterrent effect of the therapy.

What side effects are possible with Antabuse?

Possible Side Effects and Safety Information

The safety profile of disulfiram, the active ingredient in Antabuse, is formally defined by two distinct categories of adverse reactions: those arising from the medication alone and the severe symptoms caused by the consumption of alcohol.


Disulfiram-Alcohol Reaction (DAR)

This is documented as the primary serious risk. If any form of alcohol (ethanol) is consumed while the drug is active, the patient may experience a severe systemic reaction characterized by intense flushing, throbbing headache, severe nausea, vomiting, sweating, chest pain, and blurred vision. The reaction can lead to serious cardiovascular events, including severe hypotension, myocardial infarction, acute congestive heart failure, convulsions, and loss of consciousness. Official labeling specifies that the risk of this reaction persists for up to 14 days after the last dose.


Adverse Reactions from Disulfiram Alone

Adverse effects are officially classified by the physiological system affected. Common, often transient, effects noted during the initial phase of treatment include drowsiness (somnolence), headache, and dysgeusia (a metallic or garlic-like aftertaste).

Regulatory documents highlight the risk of Hepatobiliary Disorders, including Drug-Induced Liver Injury (DILI), hepatitis, and hepatic failure, some of which have been reported as fatal. Neurological adverse reactions are also documented, encompassing peripheral and optic neuritis and encephalopathy.


Safety Considerations and Constraints

Official labeling mandates that Liver Function Tests (LFTs) be performed before and periodically during treatment due to the risk of hepatotoxicity. Use is explicitly contraindicated or not recommended in individuals with severe hepatic impairment or severe cardiovascular disease. Caution is also specified for patients with conditions such as severe renal impairment, epilepsy, or psychosis. The safety and effectiveness of the medication have not been established in the pediatric population.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Disulfiram (Antabuse) documents two primary forms of overdose risk: acute overexposure to the drug alone and the severe Disulfiram-Alcohol Reaction (DAR).

Documented Manifestations and Severe Outcomes

Overdose from the drug alone may result in systemic signs, including nausea, vomiting, and tachycardia. Of specific regulatory concern are potential delayed neurological effects, such as delirium, hallucinations, and sensorimotor neuropathy. The DAR, which results from the combination with alcohol, is an acute event characterized by flushing, throbbing headache, and profound hypotension. Life-threatening outcomes documented for both scenarios include cardiovascular collapse, respiratory depression, convulsions, and coma. Patients with pre-existing coronary artery disease are noted to be at risk for more severe cardiac events, such as myocardial infarction, during the DAR.


Emergency Response and Management

Immediate medical help is mandatory in specific circumstances. Regulatory guidance states to immediately call emergency services (911) if the victim has collapsed, had a seizure, has trouble breathing, or cannot be awakened. Urgent medical attention is also required if the patient develops fever or jaundice, which may indicate developing hepatic failure. Treatment for overdosage is limited to symptomatic and supportive measures because no specific antidote is known for disulfiram. Continuous observation and measures to counteract hypotension are typically recommended during supportive care.

Therapeutic Uses of Antabuse

What Antabuse Treats: Main Uses and Benefits

Sustained Management of Alcohol Use Disorder

Disulfiram is commonly used to address the underlying condition of Alcohol Use Disorder (AUD), helping to manage the challenge of sustained sobriety. Serving as an aid in the management of selected chronic alcohol patients who seek enforced sobriety, this medication supports patients committed to recovery by introducing a supportive measure that may help prevent impulsive consumption. This contributes to easing the overall symptom load associated with the chronic, relapsing nature of the condition.

The medication is used in conditions that include Alcohol Use Disorder, chronic alcoholism, and alcohol dependence.

Supporting Sustained Abstinence and Easing Relapse Risk

The main therapeutic benefit is that it supports the goal of sustained abstinence from alcohol. Disulfiram assists with maintaining functional stability, and is relevant for managing the high risk of impulsive consumption of drinking, providing supportive relief against relapse, especially when used in conjunction with structured psychosocial treatment.

“This medication supports patients by introducing a measure that may help in managing high-risk moments in recovery.”

Targeted Context for Motivated Patients

The use of this medication is generally considered relevant for individuals with moderate to severe AUD who are highly motivated to stop drinking and who have already achieved initial abstinence. When integrated into a comprehensive care plan, the medication may assist the patient with maintaining a sense of stability during the challenging phases of long-term recovery.


Quick Fact: Support for Impulsive Consumption Risk

Regulatory References

  1. DailyMed Official Label for Disulfiram

Eligibility and Restrictions for Use

The official regulatory profile for Disulfiram (Antabuse) defines specific populations who can and cannot use the medicine. It is contraindicated and must not be used in patients who are simultaneously taking metronidazole or paraldehyde, or who have recently consumed any alcohol-containing preparations. Absolute contraindications also include serious pre-existing conditions such as severe myocardial disease, coronary occlusion, psychoses, serious organic brain damage, and advanced hepatic or renal disease.

Use is not recommended or requires extreme caution in other specific groups. For pediatric patients, the safety and effectiveness of Disulfiram have not been established. Older adults require careful dosage selection. Regulatory labeling requires the medicine to be used with caution in patients with reduced hepatic function, renal impairment, epilepsy or seizure disorders, diabetes mellitus, and hypothyroidism. Furthermore, use is generally not advised or contraindicated during pregnancy (especially the first trimester) and is not recommended while breastfeeding. The primary eligible group consists of motivated adult patients committed to abstinence from alcohol.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documentation defines several mandatory interaction-related restrictions and prohibitions for Disulfiram. The most critical restriction is the contraindication with alcohol (ethanol) in all forms, including beverages, topical products, and alcohol-containing foods, due to the risk of the severe Disulfiram-Alcohol Reaction. Patients must not have ingested alcohol for at least 12 hours before starting treatment, and the reaction risk persists for up to 14 days after stopping Disulfiram.

Documented Drug-Drug Interaction Categories

Classification Interacting Agents Official Outcome
Contraindicated Combinations Metronidazole, Paraldehyde Prohibited co-administration due to risk of psychosis and neuropathy.
Exposure-Modifying Agents Phenytoin, Warfarin, Diazepam, Theophylline Increased plasma concentrations of the co-administered drug.
Other Interacting Agents Isoniazid, Tricyclic Antidepressants, Ethylene Dibromide Increased risk of CNS adverse effects or prohibited exposure.

Disulfiram alters the clearance of several agents, such as Phenytoin and Warfarin, by inhibiting their hepatic metabolism, which formally leads to a requirement for clinical assessment when these combinations are used. The official label also advises extreme caution in patients with pre-existing hepatic impairment due to the drug's complete hepatic metabolism and potential for toxicity, which may heighten interaction severity.

Mechanism of Action

Mechanistic Action of Disulfiram

Disulfiram, the active pharmaceutical ingredient in Antabuse, is a potent inhibitor of the enzyme aldehyde dehydrogenase (ALDH). After oral administration, disulfiram is rapidly metabolized into its active component, diethyldithiocarbamate (DDC). DDC is then converted into the final metabolite, S-methyl N,N-diethylthiocarbamoyl sulfoxide, which is the primary irreversible inhibitor of ALDH.

The principal biological target of disulfiram is the cysteine residue at the active site of the ALDH enzyme, primarily the cytosolic ALDH1 and mitochondrial ALDH2 isoforms in the liver. The metabolite forms a covalent adduct with the sulfhydryl group of this cysteine residue, leading to the inactivation of the enzyme. This enzymatic inactivation blocks the intracellular pathway responsible for the oxidation of acetaldehyde (an intermediate product of ethanol metabolism) into acetate.

The resulting downstream cascade is the systemic accumulation of acetaldehyde in the plasma and tissues. This elevation of acetaldehyde concentration is the system-level physiological consequence of the drug's mechanism of action.

Dosage and Administration Information

How to Use Antabuse: Administration Guidelines

Disulfiram is administered as an oral tablet for long-term use, adhering to specific guidelines for initiation and maintenance. The first procedural constraint requires a mandatory period of abstinence from alcohol for at least 12 to 24 hours before treatment begins. The initiation of the regimen may be recommended in a supervised clinical setting in some regions.

The medication is taken once daily as a single dose. While typically taken in the morning, the dose may be administered at bedtime if the patient experiences a sedative effect. For reliable daily administration, the tablets are designed to be divisible and may be crushed and thoroughly mixed with a liquid before ingestion.

Treatment follows a two-phase dosage schedule. The initial dose is a maximum of 500 mg daily for the first one to two weeks. This is followed by the maintenance dose, which typically ranges from 125 mg to 500 mg daily, with 250 mg being a common average. The daily intake must not exceed 500 mg. The overall pattern is one of continuous, uninterrupted daily administration, sustained potentially for months or years.

For older adults, guidance advises that dose selection should be cautious, often starting at the low end of the dosing range. Use in pediatric patients has not been established.

Recent Clinical Evidence

Research evidence / Overview of studies for Antabuse

1. Evidence for Use in Alcohol Use Disorder (AUD)

Disulfiram was studied for use in patients with Alcohol Use Disorder (AUD). The evidence base relies primarily on Randomized Controlled Trials (RCTs) and Systematic Reviews that compared the medication to placebo or other pharmacological interventions. Studies primarily examined outcomes related to avoiding alcohol consumption, including continuous abstinence, time until relapse, and patient treatment retention. Findings describe patterns observed in the studies where supervised medication intake was associated with outcomes related to continuous abstinence.


2. Design and Quality of Clinical Research

Studies explored how outcomes may differ between open-label and blinded trial designs. Scientific reviews indicate that patterns related to outcomes was observed in some studies where medication intake was supervised. The overall body of evidence includes studies where the evidence quality varies and is characterized by a high degree of heterogeneity across protocols and patient groups.


3. Long-Term Studies and Extended Follow-up

Clinical trials have monitored patient outcomes over defined time intervals, typically up to 12 months. While these studies provide insight into short-term changes, data are still emerging regarding the durability of abstinence, and long-term effects are not fully established beyond the 12-month mark. Consequently, certainty remains low concerning the sustained maintenance of abstinence over extended periods.


4. Evidence in Specific Patient Populations

Research has frequently examined patients receiving concurrent psychosocial interventions. Findings suggest that the component of supervised drug administration may be a critical factor associated with measured outcomes. Scientific reviews have noted that a large proportion of participants was observed in adult male patients, meaning data for certain groups remain insufficient for female patients and other subgroups.


5. What Remains Uncertain About the Research

Key research limitation frames include the finding that follow-up durations were limited in many large-scale trials. The overall evidence base is complicated by high heterogeneity, leading to mixed findings. The comparative evidence is lacking for patients receiving unsupervised treatment, and data for certain groups remain insufficient.

Key Studies & References Disulfiram Tablet, Official Labeling Information

Frequently Asked Questions (FAQ)

Common questions about Antabuse (FAQ)

Q: Does Antabuse reduce the craving for alcohol?

A: Official information describes Disulfiram, the active ingredient in Antabuse, as an alcohol antagonist drug and a deterrent to consumption. Its function is to create a physical reaction to alcohol, which reinforces a patient’s commitment to abstinence. According to regulatory documents, the medication’s primary role is supporting sobriety through deterrence, rather than directly managing alcohol cravings.


Q: Is Antabuse considered a cure for alcohol use disorder?

A: Regulatory documents and authoritative health information sources explicitly state that Disulfiram (Antabuse) is not a cure for alcohol use disorder. The medicine is indicated to be used as part of a complete treatment program that typically includes counseling, medical support, and other therapies aimed at supporting continuous abstinence.


Q: What happens if a scheduled dose of Antabuse is missed?

A: If a scheduled dose is missed, official drug information recommends taking the dose as soon as it is remembered. However, if it is almost time for the next scheduled dose, regulatory guidance states that the patient should skip the missed dose and continue the regular schedule. Official guidance indicates that a double dose should not be taken to compensate for a missed dose.


Q: Are changes in mood or confusion a reported side effect of Antabuse?

A: Official product information and drug monographs list mood or mental changes and confusion as less common side effects. Additionally, regulatory documents mention the risk of encephalopathy and note caution in patients with a history of severe mental illness or psychosis.


Q: Can a small amount of alcohol trigger a severe reaction?

A: Yes. Regulatory documents caution against drinking any amount of alcohol, even small amounts, because the alcohol may lead to significant sickness. Official information indicates that the reaction intensity is generally proportional to the amount of alcohol ingested, and even mild reactions can occur at very low blood alcohol levels.


Q: What household products contain alcohol that must be avoided?

A: The medication requires the avoidance of alcohol in all forms, not just beverages. Patient safety guides list common products that official guidance advises avoiding, including certain sauces, vinegars, medications that contain alcohol (like cough syrups), after-shave lotions, colognes, perfumes, and rubbing alcohol.


Q: Are there certain sauces, vinegars, or foods to avoid while on Antabuse?

A: Yes, official information advises that sauces, vinegars, and all foods and beverages that contain alcohol are to be avoided as an ingredient. This includes any products that use alcohol for flavoring or preservation purposes.


Q: Does hand sanitizer or cologne containing alcohol cause a reaction on the skin?

A: Official guidance advises caution with alcohol-containing products that are applied to the skin, such as aftershave or rubbing alcohol. While less likely to cause a full systemic reaction than drinking, these products may cause headache, nausea, or local redness due to potential alcohol absorption. Official guidance advises that these products should not be used on raw skin or open wounds.


Q: Are there any concerns about taking Antabuse with other psychiatric or mood medicines?

A: Official labeling highlights that Antabuse is known to interact with certain psychiatric medications, such as Tricyclic Antidepressants, which can lead to an increased risk of side effects affecting the central nervous system. The label also advises caution in patients with severe mental illness or depression.


Q: Does the severity of the Antabuse reaction depend on the amount of alcohol consumed?

A: Yes. According to official drug information, the intensity of the Disulfiram-Alcohol Reaction is described as being proportional to the amount of alcohol consumed as well as the dose of Disulfiram taken. Consuming larger amounts of alcohol generally results in a more severe reaction.


Q: Is the risk of side effects higher with long-term use of Antabuse?

A: The continuous nature of the risk is addressed by the official safety requirements for the medication. Regulatory documents specify the mandatory requirement for periodic Liver Function Tests (LFTs) throughout treatment, due to the documented risk of Drug-Induced Liver Injury (DILI). This indicates the necessity of continuous monitoring during long-term use.


Q: Can Antabuse cause issues with sexual function or performance?

A: Yes, this is a documented adverse effect. Official side effect lists include decreased sexual ability in males (impotence) as a less common side effect associated with the medication.


Q: What are the signs of liver problems that a patient should be aware of while taking Antabuse?

A: Because of the documented risk of liver injury, the regulatory safety information describes specific observable signs. These include darkening of urine, light gray-colored stools, severe stomach pain, and yellowness of the skin or eyes (jaundice). Regular Liver Function Tests are mandatory to monitor for this risk.


Q: Can Antabuse cause numbness or tingling in the hands and feet (peripheral neuropathy)?

A: Yes, official safety information lists numbness, tingling, pain, or weakness in the hands or feet as a less common side effect. These symptoms are related to neurological adverse reactions, specifically peripheral neuritis.


Q: Is it possible to use Antabuse while pregnant or breastfeeding?

A: Official guidelines indicate that the use of Antabuse during pregnancy is generally not recommended or is listed as contraindicated, especially during the first trimester. Furthermore, regulatory documents state that use while breastfeeding is not recommended.


Q: Is Antabuse a medicine intended for long-term treatment?

A: Official guidance indicates that continuous therapy may be sustained for months or even years until a basis for sustained sobriety is established. The maintenance dose can be continued indefinitely if deemed necessary as part of the overall treatment plan.

How should Antabuse be stored and disposed of?

How to Store and Dispose of Antabuse (Disulfiram)

Antabuse (disulfiram) tablets must be stored at USP Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F). The medication requires protection from both light and moisture and must be kept in a tightly closed container to preserve its stability.

Mandatory Storage and Protection Rules

Requirement Type Official Condition
Temperature Range 20 C to 25 C (68 F to 77 F)
Environmental Control Protect from light and moisture
Child Safety Keep out of the reach of children

Disposal Instructions

Official guidance for unused or expired disulfiram recommends using a drug take-back program or mail-back disposal option. If these programs are unavailable, the medication should be mixed with an unappealing substance, placed in a sealed plastic bag, and discarded with household trash. The tablets should not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Antabuse found in:

A-Z Index: